Literature DB >> 18350612

Herbal compound 861 regulates mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells.

Lin Wang1, Bao-En Wang, Jian Wang, Pei-Gen Xiao, Xue-Hai Tan.   

Abstract

AIM: To identify the role of herbal compound 861 (Cpd 861) in the regulation of mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells (HSCs).
METHODS: mRNA levels of collagen types I and III, matrix metalloproteinase 1 (MMP-1), matrix metalloproteinase 2 (MMP-2), membrane type-1 matrix metalloproteinase (MT1-MMP), tissue inhibitor of metalloproteinase 1 (TIMP-1), and transforming growth factor beta1 (TGF-beta1) in cultured-activated HSCs treated with Cpd 861 or interferon-gamma (IFN-gamma) were determined by real-time PCR.
RESULTS: Both Cpd 861 and IFN-gamma reduced the mRNA levels of collagen type III, MMP-2 and TGF-beta1. Moreover, Cpd 861 significantly enhanced the MMP-1 mRNA levels while down-regulated the TIMP-1 mRNA expression, increasing the ratio of MMP-1 to TIMP-1 to (6.3 + 0.3)- fold compared to the control group.
CONCLUSION: The anti-fibrosis function of Cpd 861 may be mediated by both decreased interstitial collagen sythesis by inhibiting the transcription of collagen type III and TGF-beta1 and increased degradation of these collagens by up-regulating MMP-1 and down-regulating TIMP-1 mRNA levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350612      PMCID: PMC2695921          DOI: 10.3748/wjg.14.1790

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Activation of hepatic stellate cells--a key issue in liver fibrosis.

Authors:  Helen L Reeves; Scott L Friedman
Journal:  Front Biosci       Date:  2002-04-01

Review 4.  Hepatic stellate cells as a target for the treatment of liver fibrosis.

Authors:  R Bataller; D A Brenner
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 5.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream.

Authors:  David G Ginzinger
Journal:  Exp Hematol       Date:  2002-06       Impact factor: 3.084

Review 6.  Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.

Authors:  M J Arthur
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-08       Impact factor: 4.052

7.  [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].

Authors:  Shan-shan Yin; Bao-en Wang; Tai-ling Wang; Ji-dong Jia; Lin-xue Qian
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2004-08

8.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

9.  Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.

Authors:  Sandrine Henri; Christophe Chevillard; Adil Mergani; Patricia Paris; Jean Gaudart; Christophe Camilla; Hélia Dessein; Felix Montero; Nasr-Eldin M A Elwali; Osman K Saeed; Mubarak Magzoub; Alain J Dessein
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

Authors:  Pavel Taimr; Hajime Higuchi; Eva Kocova; Richard A Rippe; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more
  5 in total

Review 1.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Effects of herbal compound 861 on collagen synthesis and degradation in rat mesangial cells exposed to high glucose.

Authors:  Qing Ma; Li Zhang; Lan Yao; Hai-ping Chen; Bao-en Wang
Journal:  Chin J Integr Med       Date:  2014-03-04       Impact factor: 1.978

Review 3.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

Review 4.  Potential roles of BMP9 in liver fibrosis.

Authors:  Jianjun Bi; Shengfang Ge
Journal:  Int J Mol Sci       Date:  2014-11-11       Impact factor: 5.923

5.  Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.

Authors:  Cheng Chi; Xiao-Ya Liu; Fei Hou; Xiao-Zheng Yu; Chun-Yun Li; Li-Jian Cui; Rui-Xia Liu; Cheng-Hong Yin
Journal:  BMC Complement Altern Med       Date:  2018-02-05       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.